ADCY3(腺苷酸环化酶3)是一种重要的膜结合酶,属于腺苷酸环化酶(AC)基因家族,该家族共有9个成员(ADCY1-9)。腺苷酸环化酶家族的共性是将ATP转化为第二信使cAMP(环磷酸腺苷),从而参与多种细胞信号传导通路,调控包括代谢、细胞增殖、分化和基因表达在内的多种生理过程。ADCY3主要表达于大脑、脂肪组织和嗅觉上皮等部位,其生物学功能与嗅觉信号传导、能量代谢调节和神经元活动密切相关。在嗅觉系统中,ADCY3是嗅觉受体信号通路的关键组分,负责将气味分子激活的G蛋白偶联受体信号转化为cAMP信号,进而触发嗅觉神经元反应。在脂肪组织中,ADCY3通过调节cAMP水平影响脂肪分解和能量代谢,与肥胖和代谢综合征的发生发展相关。ADCY3的突变可能导致其功能异常,例如某些错义突变会降低酶活性,与肥胖风险增加有关,而另一些突变可能影响嗅觉功能,导致嗅觉障碍。研究发现ADCY3基因敲除小鼠表现出肥胖表型、嗅觉缺失以及葡萄糖代谢异常,表明该基因在能量平衡和感觉功能中的重要作用。ADCY3过表达可能增强cAMP信号通路活性,促进脂肪分解和能量消耗,但也可能导致信号通路过度激活引发异常细胞反应;而ADCY3表达降低则可能减少cAMP产生,抑制脂肪分解,促进脂肪堆积,增加肥胖风险。此外,ADCY3与多种疾病相关,包括肥胖症、2型糖尿病、嗅觉功能障碍以及某些神经系统疾病。在癌症中,ADCY3的表达异常可能影响肿瘤细胞的增殖和迁移。由于其在代谢和神经系统中的重要作用,ADCY3被认为是治疗代谢性疾病和某些神经疾病的潜在靶点。
This gene encodes adenylyl cyclase 3 which is a membrane-associated enzyme and catalyzes the formation of the secondary messenger cyclic adenosine monophosphate (cAMP). This protein appears to be widely expressed in various human tissues and may be involved in a number of physiological and pathophysiological metabolic processes. [provided by RefSeq, Jul 2008]
这个基因编码的腺苷酸环化酶3,其是一种膜相关酶和催化第二信使环磷酸腺苷(cAMP)的形成。这种蛋白质似乎在各种人组织进行广泛表达,并可能参与许多生理学和病理生理学的代谢过程。 [由RefSeq的,2008年7月提供]
ADCY3基因(以及对应的蛋白质)的细胞分布位置:
ADCY3基因的本体(GO)信息:
| 名称 |
|---|
| 230 Purine metabolism [PATH:hsa00230] |
| 4015 Rap1 signaling pathway [PATH:hsa04015] |
| 4020 Calcium signaling pathway [PATH:hsa04020] |
| 4024 cAMP signaling pathway [PATH:hsa04024] |
| 4022 cGMP - PKG signaling pathway [PATH:hsa04022] |
| 4114 Oocyte meiosis [PATH:hsa04114] |
| 4540 Gap junction [PATH:hsa04540] |
| 4611 Platelet activation [PATH:hsa04611] |
| 4062 Chemokine signaling pathway [PATH:hsa04062] |
| 4911 Insulin secretion [PATH:hsa04911] |
| 4912 GnRH signaling pathway [PATH:hsa04912] |
| 4913 Ovarian Steroidogenesis [PATH:hsa04913] |
| 4915 Estrogen signaling pathway [PATH:hsa04915] |
| 4914 Progesterone-mediated oocyte maturation [PATH:hsa04914] |
| 4921 Oxytocin signaling pathway [PATH:hsa04921] |
| 4918 Thyroid hormone synthesis [PATH:hsa04918] |
| 4916 Melanogenesis [PATH:hsa04916] |
| 4261 Adrenergic signaling in cardiomyocytes [PATH:hsa04261] |
| 4270 Vascular smooth muscle contraction [PATH:hsa04270] |
| 4970 Salivary secretion [PATH:hsa04970] |
| 4971 Gastric acid secretion [PATH:hsa04971] |
| 4972 Pancreatic secretion [PATH:hsa04972] |
| 4976 Bile secretion [PATH:hsa04976] |
| 4962 Vasopressin-regulated water reabsorption [PATH:hsa04962] |
| 4724 Glutamatergic synapse [PATH:hsa04724] |
| 4727 GABAergic synapse [PATH:hsa04727] |
| 4725 Cholinergic synapse [PATH:hsa04725] |
| 4723 Retrograde endocannabinoid signaling [PATH:hsa04723] |
| 4740 Olfactory transduction [PATH:hsa04740] |
| 4750 Inflammatory mediator regulation of TRP channels [PATH:hsa04750] |
| 4713 Circadian entrainment [PATH:hsa04713] |
| 5200 Pathways in cancer [PATH:hsa05200] |
| 5032 Morphine addiction [PATH:hsa05032] |
| 5414 Dilated cardiomyopathy (DCM) [PATH:hsa05414] |
| 5110 Vibrio cholerae infection [PATH:hsa05110] |
| 5166 HTLV-I infection [PATH:hsa05166] |
| 名称 |
|---|
| Activation of GABAB receptors |
| Activation of NMDA receptor upon glutamate binding and postsynaptic events |
| Adenylate cyclase activating pathway |
| Adenylate cyclase inhibitory pathway |
| Aquaporin-mediated transport |
| Ca-dependent events |
| Calmodulin induced events |
| CaM pathway |
| CREB phosphorylation through the activation of Adenylate Cyclase |
| DAG and IP3 signaling |
| DAP12 interactions |
| DAP12 signaling |
| Downstream signal transduction |
| Downstream signaling of activated FGFR1 |
| Downstream signaling of activated FGFR2 |
| Downstream signaling of activated FGFR3 |
| Downstream signaling of activated FGFR4 |
| EGFR interacts with phospholipase C-gamma |
| G alpha (i) signalling events |
| G alpha (s) signalling events |
| G alpha (z) signalling events |
| G-protein mediated events |
| GABA B receptor activation |
| GABA receptor activation |
| Glucagon signaling in metabolic regulation |
| GPCR downstream signaling |
| Hedgehog 'off' state |
| Immune System |
| Inhibition of adenylate cyclase pathway |
| Innate Immune System |
| Integration of energy metabolism |
| Metabolism |
| Neuronal System |
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell |
| NGF signalling via TRKA from the plasma membrane |
| Opioid Signalling |
| Phospholipase C-mediated cascade; FGFR2 |
| Phospholipase C-mediated cascade; FGFR3 |
| Phospholipase C-mediated cascade; FGFR4 |
| Phospholipase C-mediated cascade: FGFR1 |
| PKA activation |
| PKA activation in glucagon signalling |
| PKA-mediated phosphorylation of CREB |
| PLC beta mediated events |
| PLC-gamma1 signalling |
| PLCG1 events in ERBB2 signaling |
| Post NMDA receptor activation events |
| Signal Transduction |
| Signaling by EGFR |
| Signaling by ERBB2 |
| Signaling by FGFR |
| Signaling by FGFR1 |
| Signaling by FGFR2 |
| Signaling by FGFR3 |
| Signaling by FGFR4 |
| Signaling by GPCR |
| Signaling by Hedgehog |
| Signaling by PDGF |
| Signalling by NGF |
| Transmembrane transport of small molecules |
| Transmission across Chemical Synapses |
| Vasopressin regulates renal water homeostasis via Aquaporins |
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Inflammatory Bowel Diseases | 0.120271442 | 2 | 1 | BeFree_GWASCAT |
| Olfaction Disorders | 0.08 | 1 | 0 | RGD |
| Female infertility | 0.08 | 1 | 0 | RGD |
| Obesity | 0.002909916 | 2 | 0 | BeFree_GAD |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.002638474 | 1 | 0 | BeFree_GAD |
| Alcoholic Intoxication, Chronic | 0.002367032 | 1 | 0 | GAD |
| Overweight | 0.000271442 | 1 | 0 | BeFree |
| Major Depressive Disorder | 0.000271442 | 1 | 2 | BeFree |
| Carcinogenesis | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of stomach | 0.000271442 | 1 | 0 | BeFree |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。